论文部分内容阅读
目的 观察刺五加注射液防治蛛网膜下腔出血 (SAH)后脑血管痉挛 (CVS)的疗效。方法 将 SAH患者 44例 ,随机分为刺五加组 (2 0例 )和 SAH对照组 (2 4例 ) ,2组均于发病 48小时内接受治疗 ,SAH对照组用脱水、止血等常规疗法 ,刺五加组在常规疗法基础上加用刺五加注射液 10 0毫升 ,静脉滴注 ,每日一次 ,共 7日。结果 一个月内 ,刺五加组的 CVS发生率、死亡率明显低于 SAH对照组 (P<0 .0 5 ) ,再出血发生率 2组比较无明显差异 (P>0 .0 5 )。发病第 14天时 ,刺五加组患者的病情级别明显低于 SAH对照组 (P<0 .0 5 )。结论 刺五加注射液防治 SAH后 CVS疗效确切 ,并能促进神经功能的尽快恢复 ,且无增加再出血的危险。
Objective To observe the effect of acanthopanax senticosus injection on cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH). Methods Forty-four patients with SAH were randomly divided into Acanthopanax senticosus group (20 cases) and SAH control group (24 cases). Both groups were treated within 48 hours after onset of disease. SAH control group was treated by conventional therapy such as dehydration and hemostasis Acanthopanax group plus conventional acanthopanax senticosus injection 10 0 ml, intravenously, once daily for a total of 7 days. Results The incidence of CVS and mortality in Acanthopanax senticosus group were significantly lower than those in SAH control group (P <0.05) within one month. There was no significant difference in the incidence of rebleeding between the two groups (P> 0.05). On the 14th day of onset, the severity of the Acanthopanax group was significantly lower than that of the SAH control group (P <0.05). Conclusion Acanthopanax senticosus CVS treatment after SAH curative effect is exact and can promote the recovery of nerve function as soon as possible, and without increasing the risk of rebleeding.